News
-
-
-
PRESS RELEASE
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Xenetic Biosciences, Inc. and Santersus AG announce a definitive share exchange agreement to form a Nasdaq-listed clinical-stage company targeting neutrophil extracellular traps (NETs) in multiple disease areas -
-
-
-
-
-
-